On March 26 in Toronto, more than 200 leaders, innovators, investors, and partners from Canada’s genomics and life sciences ecosystem gathered for Connect‑Bio Expanded—an event dedicated to omics technologies and their strategic role in advancing innovation in health and life sciences. This dynamic day was driven by a shared ambition: to foster collaboration, accelerate partnerships,…
CQDM is pleased to launch a call for ideas for the upcoming CQDM Connect-Pharma: Pitch Day, focused on AI-Driven Multi-Omics Integration for Drug Discovery. Selected applicants will present their innovations to experts from CQDM’s global pharmaceutical members on May 28, 2026. Our objective is to bring ground-breaking, innovative Canadian research to CQDM’s pharmaceutical members and…
Discover the story of Epitopea, a biotechnology company specializing in immunotherapy, born from a research project supported by CQDM. Based in Montréal and Cambridge (UK), Epitopea is developing next‑generation therapeutic vaccines. Their goal: to train the immune system to precisely recognize and target tumor‑specific antigens, opening up new possibilities in cancer treatment. From the earliest…
The strategic consortium PROTEO, in collaboration with CQDM, is pleased to announce the upcoming Connect‑BIO – Quebec Forum on Biofabrication, a must‑attend event for researchers, innovators, and life sciences entrepreneurs. This gathering will bring together experts, scientists, and industry leaders to discuss the latest advances, challenges, and opportunities shaping Quebec’s biofabrication ecosystem. What to Expect…
UP TO $1.6 MILLION AVAILABLE TO SUPPORT COLLABORATIVE BRAIN RESEARCH PROJECTSBrain Canada Foundation (Brain Canada) and CQDM are joining forces to support interprovincial collaborative biopharmaceutical research and development (R&D) projects on the brain. This partnership creates a unique funding opportunity that brings together experts from academia and industry to support the development of platforms, tools and biopharmaceuticals that…
Maïlyn holds a PhD in Molecular and Cellular Biology from the Université de Sherbrooke. Her research explores DNA repair mechanisms under replicative stress to identify new therapeutic targets in oncology. She has presented her work nationally and internationally and has received multiple awards and scholarships. She also holds an MBA from IAE Poitiers. 👉 Discover…
We are pleased to welcome Julien Dufort-Gervais as a Project Manager at CQDM. With strong experience in preclinical development and fundamental research in Québec, Julien will leverage his expertise to support the biopharmaceutical innovation projects funded by the organization. Julien holds a Master’s degree in Pharmacology from Université de Montréal and has recognized expertise in…
CQDM, in partnership with NGen, invites you to Connect-Bio | Bringing Together Canada’s Genomics Ecosystem, a flagship event uniting Canada’s genomics, life sciences, and biopharmaceutical innovation ecosystem. This Toronto edition will bring together companies and organizations active in genomics or interested in the field—from pharmaceutical companies to innovative startups and service providers, as well as…
Quand l’intelligence artificielle redéfinit la recherche biopharmaceutique, s’entourer d’une expertise de premier plan est plus essentiel que jamais !Le CQDM est très heureux d’accueillir Radia Johnson et Artem Cherkasov au sein de son Comité consultatif scientifique. Radia Johnson est biologiste computationnelle et dirigeante en sciences de la vie, spécialisée dans la découverte de biomarqueurs et…
Welcome Juliette Sabbatani, our new project manager at CQDM ! 🎉 Juliette Sabbatani is an innovative scientist with nearly ten years of experience in the pharmaceutical industry and drug discovery. A co-inventor on ten patents, she has led complex projects across academic, biotech, and startup environments. 🌟 Learn more about her : Juliette Sabbatani